PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease

“Mini-mental state”

Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 85.9K citations

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Warren J. Strittmatter, Ann M. Saunders, D. E. Schmechel et al. · Proceedings of the National Academy of Sciences · 1993 · 4.3K citations · Full text

Type 4, Genetics, Genetic Epidemiology +18

Statins and the risk of dementia

Hershel Jick, GL Zornberg, Sudha Seshadri et al. · The Lancet · 2000 · 1.7K citations

Alzheimer's Disease, Aging, Vascular Cognitive Disorder +8

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

Benjamin Wolozin · Archives of Neurology · 2000 · 1.4K citations

A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

William R. Oliver, Jennifer L. Shenk, Mike R. Snaith et al. · Proceedings of the National Academy of Sciences · 2001 · 1K citations · Full text

Molecular Pharmacology, Metabolic Syndrome, Insulin Signaling +15